Hipercortisolismo subclínico en pacientes con osteoporosis

1. Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am. 2005;34:341-56
2. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593-602.
3. Reincke M. Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am. 2000;29:43-56.
4. Chidiac RM, Aron DC. Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am. 1997;26:233-53.
5. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev. 1995;16:460-84.
6. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273-85.
7. Terzolo M, Osella G, Alı` A, Borretta G, Cesario F, Paccotti P, et al. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf). 1998;48:89-97.
8. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscoso L, et al. Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 2000;85:1440-8.
9. Terzolo M, Pia A, Alı` A, Osella G, Reimondo G, Bovio S, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87:998-1003.
10. Angeli A, Terzolo M. Adrenal incidentaloma—a modern disease with old complications [Editorial]. J Clin Endocrinol Metab. 2002;87:4869-71.
11. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammisa M, Modoni S, et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab. 1999;84:2381-5.
12. Chiodini I, Torlontano M, Carnevale V, Guglielmi G, Cammisa M, Trischitta V, et al. Bone loss rate in adrenal incidentalomas: a longitudinal study. J Clin Endocrinol Metab. 2001;86:5337-41.
13. Chiodini I, Tauchmanova` L, Torlontano M, Battista C, Guglielmi G, Cammisa M, et al. Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism. J Clin Endocrinol Metab. 2002;87:5491-4.
14. Devogelaer JP. Incidentaloma, glucocorticoid excess and low bone mineral density: a coincidence? Eur J Endocrinol. 2001;145:237-9.
15. Hadjidakis D, Tsagarakis S, Roboti C, Sfakianakis M, Iconomidou V, Raptis SA, et al. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clin  Edocrinol (Oxf). 2003;58:72-7.
16. Tauchmanova` L, Rossi R, Nuzzo V, del Puente A, Esposito-del Puente A, Pizzi C, et al. Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with  endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol. 2001;145:241-7.
17. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, et al. Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996;44:717-22.
18. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, et al. Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003;88:5808-13.
19. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol. 2005;153:837-44.
20. Khanine V, Fournier JJ, Requeda E, Luton JP, Simon F, Crouzet J. Osteoporotic fractures at presentation of Cushing’s disease: two case reports and a literature review. Joint Bone Spine. 2000;67:341-5.
21. Kann P, Laudes M, Piepkorn B, Heintz A, Beyer J. Suppressed levels of serum cortisol after high-dose oral dexamethasone administration differ between healthy postmenopausal females and patients with established primary vertebral osteoporosis. Clin Rheumatol. 2001;20:25-9.
22. Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab. 1998;83:1163-7.
23. Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med. 2003;138:980-91.
24. Terzolo M, Bovio S, Pia A, Conton PA, Reimondo G, Dall’Asta C, et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol. 2005;153:307-15.
25. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am. 2001;30:729-47.
26. Guglielmi G, Giannatempo GM, Blunt BA, Grampp S, Glu¨er CC, Cammisa M, et al. Spinal bone mineral density by quantitative CT in a normal Italian population. Eur Radiol. 1995;5:269-75.
27. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-48.
28. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929-36.
29. Reynolds RM, Dennison EM, Walker BR, Syddall HE, Wood PJ, Andrew R, et al. Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif Tissue Int. 2005;77:134-8.